Wolverine Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Wolverine Trading's ARKG Position: Q3 2025 in Review
Wolverine Trading increased its ARK Genomic Revolution ETF (ARKG) stake by 11% in Q3 2025, buying an estimated $102K and bringing the position to 42,447 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.
Wolverine Trading first reported a position in ARKG in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.9M in Q1 2024. 231 funds tracked by Wall St. Rank hold ARKG as of Q3 2025.
- Wolverine Trading held 42,447 shares of ARK Genomic Revolution ETF worth $1.16M as of Q3 2025.
- Wolverine Trading bought 4,036 ARK Genomic Revolution ETF shares in Q3 2025, an estimated $102K.
- ARK Genomic Revolution ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2745 holding.
- Wolverine Trading first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 19 quarters since.
- Wolverine Trading's ARK Genomic Revolution ETF position peaked at $2.9M in Q1 2024.
- 231 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.